A study of the genotoxicity, fertility and early embryonic development toxicity of rotigotine behenate extended‐release microspheres
Basic & Clinical Pharmacology & Toxicology · 2024
DOI: 10.1111/bcpt.13972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Xinyu Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Yantai University & State Key Laboratory of Long-acting and Targeting Drug Delivery Technologies, Yantai, China. Hauptthemen laut MEDLINE: Parkinson Disease, Tetrahydronaphthalenes, Thiophenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taishan Scholar Project (Kehao Zhao), Taishan Scholar Project of Shandong Province.
Abstract (Originalsprache)
Continuous dopaminergic stimulation (CDS) has become an important strategy for the development of drugs to treat Parkinson's disease (PD). Rotigotine behenate extended‐release microspheres (RBEM) for injection represent a new treatment regime for CDS and are undergoing clinical trials. In this study, we aimed to investigate the effect of RBEM on genotoxicity, fertility and early embryonic development. We used the Ames test, Chinese hamster lung (CHL) cell chromosome aberration test and the mouse bone marrow micronucleus test, to evaluate the genotoxicity of RBEM. These tests were all negative, thus indicating that RBEM did not induce genotoxicity. In reproduction toxicity testing in male rats on obvious findings following intramuscular administration (i.m.) of RBEM at up to 540 mg/kg ( P > 0.5), when female rats were administered with RBEM in the dose range of 60 to 540 mg/kg given (i.m.), there were clear effects on fertility and early embryonic development. These results indicated that RBEM could induce toxicity in female rats and exert effect on fertility and early embryonic development stage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Yantai University & State Key Laboratory of Long-acting and Targeting Drug Delivery Technologies, Yantai, China.
- Luye Pharmaceutical Co., Ltd. (Luye Pharma), Yantai, China.
- WestChina-Frontier PharmaTech Co. (WCFP) & National Chengdu Center for Safety Evaluation of Drugs (NCCSED), Chengdu, China.
ORCID-Profile: Xin Yu
Förderung
- National Natural Science Foundation of China
- Taishan Scholar Project (Kehao Zhao)
- Taishan Scholar Project of Shandong Province
Zitieren
APA
Zhao, X., Guo, C., Zhang, H., Yu, X., Du, G., Tian, J., Liu, W., Song, T., Chen, X., & Guo, W. (2024). A study of the genotoxicity, fertility and early embryonic development toxicity of rotigotine behenate extended‐release microspheres. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13972
Vancouver
Zhao X, Guo C, Zhang H, Yu X, Du G, Tian J, et al. A study of the genotoxicity, fertility and early embryonic development toxicity of rotigotine behenate extended‐release microspheres. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.13972
BibTeX
@article{Zhao2024,
author = {Zhao, Xinyu and Guo, Chunmin and Zhang, Hong and Yu, Xin and Du, Guagnying and Tian, Jingwei and Liu, Wanhui and Song, Tao and Chen, Xiaobo and Guo, Wei},
title = {A study of the genotoxicity, fertility and early embryonic development toxicity of rotigotine behenate extended‐release microspheres},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
doi = {10.1111/bcpt.13972}
}
EUVIMED